Vikram Malhi
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
-
- Drug Transport and Resistance Mechanisms
Papers in
-
- Hedgehog Signaling Pathway Studies 9
- PI3K/AKT/mTOR signaling in cancer 3
- Protein Degradation and Inhibitors 2
- Oncology 9
- Cancer-related Molecular Pathways 3
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Richard Graham (9 shared papers)Sophie Mukadam (1 shared paper)Jin Y. Jin (1 shared paper)Yuan Chen (1 shared paper)Jane R. Kenny (1 shared paper)Bert L. Lum (3 shared papers)Cornelis E. C. A. Hop (4 shared papers)Jennifer A. Low (6 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (4 papers)Journal of Clinical Oncology (3 papers)Drug Metabolism and Disposition (3 papers)Molecular Cancer Therapeutics (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United StatesFranceSpain
In The Last Decade
Vikram Malhi
23 papers receiving 407 citations
Peers
Comparison fields: 5 of 62
- Pharmacology 81
- Oncology 130
- Dermatology 39
- Pharmacy 21
- Molecular Biology 234
Countries citing papers authored by Vikram Malhi
This map shows the geographic impact of Vikram Malhi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikram Malhi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikram Malhi more than expected).
Fields of papers citing papers by Vikram Malhi
This network shows the impact of papers produced by Vikram Malhi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikram Malhi. The network helps show where Vikram Malhi may publish in the future.
Co-authors
The 25 scholars most cited alongside Vikram Malhi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 81 | |
| 2 | 2011 | 60 | |
| 3 | 2012 | 49 | |
| 4 | 2011 | 48 | |
| 5 | 2021 | 48 | |
| 6 | 2016 | 22 | |
| 7 | 2011 | 18 | |
| 8 | 2012 | 17 | |
| 9 | 2021 | 16 | |
| 10 | 2021 | 15 | |
| 11 | 2022 | 10 | |
| 12 | 2020 | 10 | |
| 13 | 2021 | 7 | |
| 14 | 2021 | 7 | |
| 15 | 2021 | 4 | |
| 16 | 2023 | 4 | |
| 17 | 2023 | 2 | |
| 18 | 2023 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 2011 | 2 |
About Vikram Malhi
Vikram Malhi is a scholar working on Molecular Biology, Oncology, Pharmacy, Pharmacology and Pathology and Forensic Medicine, having authored 23 papers that have together received 427 indexed citations. Recurring topics across this work include Hedgehog Signaling Pathway Studies (9 papers), Oral and gingival health research (6 papers), Pharmacogenetics and Drug Metabolism (6 papers), Cancer-related Molecular Pathways (3 papers), Estrogen and related hormone effects (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Protein Degradation and Inhibitors (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Pharmacology (81 citations), Oncology (130 citations), Dermatology (39 citations), Pharmacy (21 citations) and Molecular Biology (234 citations). Vikram Malhi has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Richard Graham, Sophie Mukadam, Jin Y. Jin, Yuan Chen, Jane R. Kenny, Bert L. Lum, Cornelis E. C. A. Hop, Jennifer A. Low, Dawn Colburn and Young G. Shin. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology, Drug Metabolism and Disposition, Molecular Cancer Therapeutics and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.